IvCB, Hollandbio, and the Netherlands British Chamber of Commerce (NBCC), together with other international Chambers of Commerce and partners, invite you on the 29th of May 2026 for a sector event on the role of Biotech & Life Sciences innovation in strengthening the strategic and economic resilience of the Netherlands.

The geopolitical landscape has been in significant transition over the past couple of years. Where the COVID-19 crisis made it clear that the Netherlands is dependent on international supply chains during a time of a global crisis, current trends have implications with regards to our dependency on supply chains worldwide for the longer term.

In Europe, there are already successful examples of how to stimulate innovation so why should we reinvent the wheel when we can learn from our European allies? And how do we translate our findings into concrete action in the Netherlands? Join us as we explore European best practices and their implications for strengthening Biotech & Life Science innovation and future earning capacity in the Netherlands.

Program

09:00 – 09:30 Walk-in & registration

09:30– 09:40 Opening 

09:40 – 10:00 Keynote 

10:05 – 10:35 Panel 1: “Strategic autonomy” in Biotech & Life Sciences – What does it mean?

10:35 – 11:00 Coffee Break

11:00 – 11:30 Panel 2: Accelerating innovation through collaboration

11:30 – 12:00 Panel 3: Investment, access and long-term prosperity

12:00 Lunch

The event will bring together Members of Parliament, senior policymakers, representatives of leading life sciences companies, academic institutions and healthcare innovation leaders.

Practical information

· Date: 29th May 2026

· Time: 9:00-13:00, including lunch

· Location: Kadans Science Partner Plus Ultra Leiden. Emmy Noetherweg 2, 2333 BK Leiden